Archer-Daniels-Midland Company

🇺🇸New York Stock Exchange
Back to all articles
Archer-Daniels-Midland Company stock analysis ADM overview
Very Bearish -75

Why Archer-Daniels-Midland Stock Is Plunging Today

📉 ADM shares dropped nearly 20% as of 10:30 ET Monday following the announcement that CFO Vikram Luthar was placed on administrative leave.

🔍 The company is undergoing an internal investigation by outside counsel and the board's audit committee specifically focused on accounting practices in its nutrition business.

📅 ADM expects to delay its fourth-quarter and full-year 2023 financial results from the usual late-January reporting date while cooperating with an SEC voluntary document request.

💰 Management projects adjusted earnings per share for 2023 will be above $6.90, which is below the $7.28 analyst consensus estimate.

📉 Barclays downgraded its rating on ADM from overweight to underweight in response to the CFO news and implied weaker margins.

📊 The stock has underperformed the S&P 500 over the past five years even before the recent accounting-related decline.

⚠️ Analysts advise investors to wait for clarity rather than buying the drop due to the uncertainty surrounding the ongoing investigation.

Risk Factors
  • 📉 CFO Vikram Luthar placed on administrative leave as part of an internal investigation into accounting practices.
  • 📅 Company expects to delay fourth-quarter and full-year 2023 financial results from the usual late-January reporting date.
  • 💰 Projected adjusted earnings per share for 2023 are above $6.90, which is below the $7.28 analyst consensus.
  • 📉 Barclays downgraded rating from overweight to underweight due to CFO news and implied weaker margins.
  • 📊 Stock has underperformed the S&P 500 over the past five years prior to the recent drop.
  • ⚠️ Company is cooperating with an SEC voluntary document request regarding its nutrition business accounting.
Full Analysis
Archer-Daniels-Midland (NYSE: ADM) shares plummeted nearly 20% on Monday after the company placed its CFO, Vikram Luthar, on administrative leave. This move is part of an internal investigation by outside counsel and the board's audit committee specifically focused on accounting practices within the company's nutrition business. Following the announcement of Ismael Roig as the interim CFO, ADM confirmed it is cooperating with a Securities and Exchange Commission voluntary document request. Consequently, the company expects to delay its fourth-quarter and full-year 2023 financial results from their usual late-January reporting date. Management maintains an expectation of adjusted earnings per share above $6.90 for 2023, which falls below the $7.28 analyst consensus. Wall Street reaction has been sharply negative, with Barclays downgrading its rating on ADM from overweight to underweight due to the CFO news and implied weaker margins. Analysts warn that markets dislike the uncertainty surrounding the investigation, suggesting investors should wait for clarity rather than rushing to buy the dip. The stock has also underperformed the S&P 500 over the past five years prior to this latest downturn. The article concludes by noting that major investment services like The Motley Fool's Stock Advisor have not included ADM in their current top stock picks, citing a lack of immediate bullish catalysts despite the significant price drop. The overall tone suggests caution given the combination of regulatory scrutiny, accounting concerns, and historical underperformance.